HPGC Renmintongtai Pharmaceutical Corporation (SHSE:600829) announced that it will receive an equity round of funding from returning investor Harbin Pharmaceutical Group Co., Ltd. (SHSE:600664) on April 30, 2019.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.4 CNY | -2.14% | -5.74% | -18.16% |
1st Jan change | Capi. | |
---|---|---|
-18.16% | 524M | |
+18.64% | 72.89B | |
-6.00% | 23.48B | |
+4.65% | 8.67B | |
+9.32% | 8.51B | |
-25.47% | 7.71B | |
+13.37% | 5.21B | |
+1.58% | 4.23B | |
+5.71% | 4.08B | |
+1.24% | 3.99B |
- Stock Market
- Equities
- 600829 Stock
- News HPGC Renmintongtai Pharmaceutical Corporation
- HPGC Renmintongtai Pharmaceutical Corporation announced that it expects to receive funding from Harbin Pharmaceutical Group Co., Ltd.